CCL2 and atherosclerosis: In contrast, salusin-α could selectively down-regulate the levels of IL-6 and TNF-α in plasma not MCP-1 and VCAM-1 in the aorta, suggesting little effects of salusin-α on inflammation in atherosclerosis progression.